Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Characterization of conformation-sensitive antibodies to ADAMTS13, the von Willebrand cleavage protease.

Sauna ZE, Okunji C, Hunt RC, Gupta T, Allen CE, Plum E, Blaisdell A, Grigoryan V, Geetha S, Fathke R, Soejima K, Kimchi-Sarfaty C.

PLoS One. 2009 Aug 5;4(8):e6506. doi: 10.1371/journal.pone.0006506.

2.

Novel monoclonal antibody-based enzyme immunoassay for determining plasma levels of ADAMTS13 activity.

Kato S, Matsumoto M, Matsuyama T, Isonishi A, Hiura H, Fujimura Y.

Transfusion. 2006 Aug;46(8):1444-52.

PMID:
16934083
3.

The active conformation of von Willebrand factor in patients with thrombotic thrombocytopenic purpura in remission.

Groot E, Fijnheer R, Sebastian SA, de Groot PG, Lenting PJ.

J Thromb Haemost. 2009 Jun;7(6):962-9. doi: 10.1111/j.1538-7836.2009.03433.x.

4.

Detection of intracellular ADAMTS13, a secreted zinc-metalloprotease, via flow cytometry.

Geetha S, Allen CE, Hunt RC, Plum E, Garfield S, Friedman SL, Soejima K, Sauna ZE, Kimchi-Sarfaty C.

Cytometry A. 2009 Aug;75(8):675-81. doi: 10.1002/cyto.a.20748.

5.

Multiple B-cell clones producing antibodies directed to the spacer and disintegrin/thrombospondin type-1 repeat 1 (TSP1) of ADAMTS13 in a patient with acquired thrombotic thrombocytopenic purpura.

Luken BM, Kaijen PH, Turenhout EA, Kremer Hovinga JA, van Mourik JA, Fijnheer R, Voorberg J.

J Thromb Haemost. 2006 Nov;4(11):2355-64. Epub 2006 Aug 8.

6.

VH1-69 germline encoded antibodies directed towards ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura.

Pos W, Luken BM, Kremer Hovinga JA, Turenhout EA, Scheiflinger F, Dong JF, Fijnheer R, Voorberg J.

J Thromb Haemost. 2009 Mar;7(3):421-8. doi: 10.1111/j.1538-7836.2008.03250.x.

7.

Identification of epitopes on ADAMTS13 recognized by a panel of monoclonal antibodies with functional or non-functional effects on catalytic activity.

Igari A, Nakagawa T, Moriki T, Yamaguchi Y, Matsumoto M, Fujimura Y, Soejima K, Murata M.

Thromb Res. 2012 Sep;130(3):e79-83. doi: 10.1016/j.thromres.2012.06.006. Epub 2012 Jun 20.

PMID:
22721582
8.
9.

Analysis on the molecular species and concentration of circulating ADAMTS13 in Blood.

Soejima K, Nakamura H, Hirashima M, Morikawa W, Nozaki C, Nakagaki T.

J Biochem. 2006 Jan;139(1):147-54.

PMID:
16428330
10.

The spacer domain of ADAMTS13 contains a major binding site for antibodies in patients with thrombotic thrombocytopenic purpura.

Luken BM, Turenhout EA, Hulstein JJ, Van Mourik JA, Fijnheer R, Voorberg J.

Thromb Haemost. 2005 Feb;93(2):267-74.

PMID:
15711742
11.

Recent advances in thrombotic thrombocytopenic purpura.

Sadler JE, Moake JL, Miyata T, George JN.

Hematology Am Soc Hematol Educ Program. 2004:407-23. Review.

PMID:
15561695
12.

Epitope mapping of ADAMTS13 autoantibodies in acquired thrombotic thrombocytopenic purpura.

Klaus C, Plaimauer B, Studt JD, Dorner F, Lämmle B, Mannucci PM, Scheiflinger F.

Blood. 2004 Jun 15;103(12):4514-9. Epub 2004 Feb 19.

13.

Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of 11 cases.

Fakhouri F, Vernant JP, Veyradier A, Wolf M, Kaplanski G, Binaut R, Rieger M, Scheiflinger F, Poullin P, Deroure B, Delarue R, Lesavre P, Vanhille P, Hermine O, Remuzzi G, Grünfeld JP.

Blood. 2005 Sep 15;106(6):1932-7. Epub 2005 Jun 2.

14.

An autoantibody epitope comprising residues R660, Y661, and Y665 in the ADAMTS13 spacer domain identifies a binding site for the A2 domain of VWF.

Pos W, Crawley JT, Fijnheer R, Voorberg J, Lane DA, Luken BM.

Blood. 2010 Feb 25;115(8):1640-9. doi: 10.1182/blood-2009-06-229203. Epub 2009 Dec 23.

15.

TTP and ADAMTS13: When Is Testing Appropriate?

Mannucci PM, Peyvandi F.

Hematology Am Soc Hematol Educ Program. 2007:121-6. Review.

PMID:
18024619
16.

The VWF/ADAMTS13 axis in the antiphospholipid syndrome: ADAMTS13 antibodies and ADAMTS13 dysfunction.

Austin SK, Starke RD, Lawrie AS, Cohen H, Machin SJ, Mackie IJ.

Br J Haematol. 2008 May;141(4):536-44. doi: 10.1111/j.1365-2141.2008.07074.x. Epub 2008 Mar 12.

PMID:
18341632
17.

ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission.

Peyvandi F, Lavoretano S, Palla R, Feys HB, Vanhoorelbeke K, Battaglioli T, Valsecchi C, Canciani MT, Fabris F, Zver S, Réti M, Mikovic D, Karimi M, Giuffrida G, Laurenti L, Mannucci PM.

Haematologica. 2008 Feb;93(2):232-9. doi: 10.3324/haematol.11739. Epub 2008 Jan 26.

18.

Molecular basis of ADAMTS13 dysfunction in thrombotic thrombocytopenic purpura.

Manea M, Karpman D.

Pediatr Nephrol. 2009 Mar;24(3):447-58. doi: 10.1007/s00467-008-0986-8. Epub 2008 Sep 20. Review.

PMID:
18807073
19.

ADAMTS13 related markers and von Willebrand factor in plasma from patients with thrombotic microangiopathy (TMA).

Kobayashi T, Wada H, Nishioka N, Yamamoto M, Matsumoto T, Tamaru T, Nomura S, Masuya M, Mori Y, Nakatani K, Nishikawa M, Katayama N, Nobori T.

Thromb Res. 2008;121(6):849-54. Epub 2007 Sep 27.

PMID:
17900666
20.

Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura.

Tsai HM.

J Mol Med (Berl). 2002 Oct;80(10):639-47. Epub 2002 Sep 5. Review.

PMID:
12395148

Supplemental Content

Support Center